Invention Grant
- Patent Title: Enhanced differentiation of mesenchymal stem cells
-
Application No.: US14802857Application Date: 2015-07-17
-
Publication No.: US10053670B2Publication Date: 2018-08-21
- Inventor: Basil M. Hantash
- Applicant: Escape Therapeutics, Inc.
- Applicant Address: US CA San Jose
- Assignee: Escape Therapeutics, Inc.
- Current Assignee: Escape Therapeutics, Inc.
- Current Assignee Address: US CA San Jose
- Agency: Wilmer Cutler Pickering Hale and Dorr LLP
- Main IPC: C12N5/0775
- IPC: C12N5/0775 ; A61K35/28
Abstract:
Isolated populations of mesenchymal stem cells (MSCs) are provided, including mammalian mesenchymal stem cells (MSCs) characterized by the lack of CD54 (CD54−) or low cell-surface CD54 (CD54low). Methods of in vitro cell differentiation and methods of treatment using said isolated populations are also provided.
Public/Granted literature
- US20160130556A1 ENHANCED DIFFERENTIATION OF MESENCHYMAL STEM CELLS Public/Granted day:2016-05-12
Information query
IPC分类:
